01406 CLARITY MEDICAL
- 0.540
- 0.0000.00%
CLARITY MEDICAL News
Xiushentang (08200.HK) acquired 15 million shares of Clarity Medical Group Holdings at a cost of approximately HK$8.95 million
Gelonghui, April 8, 丨 Xiushentang (08200.HK) announced that on April 8, 2024, the Group acquired a total of 15 million shares of the target company (Clarity Medical Group Holdings Limited) at a total cost of about HK$8.95 million (not including transaction costs) through in-market transactions carried out on the Stock Exchange, which is equivalent to approximately HK$0.60 per share. During the 12-month period prior to the date of the target company's acquisition, the Group acquired a total of 1.3 million shares of the target company at a total cost of approximately HK$923,900 (not including transaction costs). After the acquisition of the target company, the Group held a total of 1,630
Prime Sage International Limited sold 7 million shares of Clear Medical (01406.HK) common shares worth approximately HK$3.276,000 off the market
On March 27, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 27, Prime Sage International Limited sold $7 million of $Clarity Healthcare (01406.HK) shares worth about HK$3.276,000 off the market at an average price of HK$0.468 per share on March 18. After the sale, Prime Sage International Limited's latest shareholding was 77.7846 million shares, and the good position ratio dropped from 16.05% to 14.73%. This transaction involves
Xie Weiye sold 7 million common shares of Clear Medical (01406.HK) off the market, worth about HK$3.276,000
On March 26, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 26, Xie Weiye sold $7 million of $Clarity Healthcare (01406.HK) shares worth about HK$3.276,000 off the market at an average price of HK$0.468 per share on March 18. After the sale, Xie Weiye's latest shareholding was 78,263,400 shares, and the good position ratio dropped from 16.14% to 14.82%. This transaction involves other related parties: Ultimate Bliss Limited and Xie Weiye. Photo source: Stock Exchange equity disclosure (partial table of this incident) What
Prime Sage International Limited sold 5.577,500 common shares of Clear Healthcare (01406.HK) worth approximately HK$3,0119 million
On March 22, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 22, Prime Sage International Limited sold $5.577,500 common shares of $Clarity Healthcare (01406.HK) at an average price of HK$0.54 per share on March 21, worth approximately HK$3,011,900. After the sale, Prime Sage International Limited's latest shareholding was 84.7846 million shares, and the good position ratio dropped from 17.11% to 16.05%. This transaction involves
Prime Sage International Limited sold 10.272,500 common shares of Clear Healthcare (01406.HK) worth approximately HK$5.6088 million
On March 19, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 19, Prime Sage International Limited sold $10.272,500 common shares of $Clarity Healthcare (01406.HK) at an average price of HK$0.546 per share on March 18, worth approximately HK$5.6088 million. After the sale, Prime Sage International Limited's latest shareholding was 93.6621 million shares, and the good position ratio dropped from 19.06% to 17.11%. book
Clarity Healthcare (01406.HK): Independent Non-Executive Director Lau Yun-yi passed away
On February 8, Ge Longhui | Clear Medical (01406.HK) issued an announcement. Professor Liu Yunyi, an independent non-executive director of the company, a member of the Audit Committee and Remuneration Committee, passed away on February 7, 2024.
This Insider Has Just Sold Shares In Clarity Medical Group Holding
We'd be surprised if Clarity Medical Group Holding Limited (HKG:1406) shareholders haven't noticed that the Executive Director, Wai Ip Tse, recently sold HK$2.0m worth of stock at HK$0.61 per share.
Ultimate Bliss Limited sold 3.276,300 common shares of Clear Medical (01406.HK) worth approximately HK$19.03 million
It was reported on January 23 that, according to documents disclosed by the Hong Kong Stock Exchange on January 23, Ultimate Bliss Limited sold $3.276,300 common shares of $Clarity Healthcare (01406.HK) at an average price of HK$0.6075 per share on January 22, worth approximately HK$19.03 million. After the sale, Ultimate Bliss Limited's latest shareholding was 101 million shares, and the good position ratio dropped from 19.76% to 19.14%. This transaction involves other related parties: TMF (Cayman) Lt
Medicine 2023: Winter is still around the corner, spring is getting stronger, innovative drugs “going overseas” welcome a big explosion, health insurance policies continue to warm | year-end inventory
“Science and Technology Innovation Board Daily”, December 27 (Reporter Xu Hong) Although the pharmaceutical industry is still cold in winter in 2023, the signs of “recovery” continue to increase. In particular, as the overall health insurance policy enters the optimization stage, not only will fundamental risks be further released, but it is also expected to greatly increase the certainty of growth of domestically produced innovative drugs.
清晰醫療：二零二三/二四年中期報告
Clear Healthcare (1406.HK): It takes longer to achieve goals
Clear Healthcare (01406.HK) achieved total revenue of approximately HK$100 million in the first half of 2023/24, down about 5.6% from the same period last year. At the same time, it received an increase in sharing and the opening of services invested in the [new Tsim Sha Tsui Centre]
Don't Ignore The Insider Selling In Clarity Medical Group Holding
Anyone interested in Clarity Medical Group Holding Limited (HKG:1406) should probably be aware that the Executive Director, Wai Ip Tse, recently divested HK$2.0m worth of shares in the company, at an
Ultimate Bliss Limited sold 3.125 million common shares of Clear Healthcare (01406.HK), worth approximately HK$2 million
On December 5, according to documents disclosed by the Hong Kong Stock Exchange on December 5, Ultimate Bliss Limited sold $3.125 million common shares of $Clear Healthcare (01406.HK) on November 30 at an average price of HK$0.64 per share, worth about HK$2 million. After the sale, the latest number of shares held by Ultimate Bliss Limited was 104 million shares, and the good position ratio fell from 20.36% to 19.76%. This transaction involves other related parties: Xie Weiye, Prime Sage Inter
CLARITY MEDICAL: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Clear Healthcare (01406.HK) plans to hold a board meeting on November 28 to approve interim results
On November 13, Gelonghui Healthcare (01406.HK) announced that the board of directors will hold a board meeting on November 28, 2023 (Tuesday) to (including) approve the interim results of the company and its subsidiaries for the six-month period ending September 30, 2023 and a proposal to consider the payment of interim dividends (if any).
Clarity Arm Saintford Hires Contractor for Renovation of TMT Medical Centre
Clarity Medical Group Holding (HKG:1406) said indirect, wholly-owned subsidiary Saintford has awarded a HK$525,338 contract to Wing Keung Contracting and Engineering, mandating the contractor to renov
Clarity Medical to Swing to April-September Loss
Clarity Medical (HKG:1406) expects a net loss of up to HK$24 million for the six months ended Sept. 30, as compared to a net profit of HK$7.9 million during the year-ago period. The anticipated turnar
CLARITY MEDICAL: Annual Report 2023
Clear Healthcare (01406.HK): Getting out of the slump is imminent
We participated in a visit held by Clear Healthcare (01406.HK) last week. We visited the newly opened EVO ICL Premium Center, ii, located on the 7th floor of Huifeng Center
Clear Healthcare (01406) awarded a total of 35.4562 million reward shares
According to the Zhitong Finance App, Clear Healthcare (01406) announced that on July 4, 2023, the company awarded rewards to a number of eligible participants (i.e. grantees) in accordance with the share reward plan, involving a total of 354.5562 million reward shares. The purpose of awarding rewards is to align the interests of the grantor with those of the Group through share ownership, dividends and other allocations of share payments and/or enhancement of the value of the shares, to recognize the grantor's contributions, and to incentivize the long-term investment of the underwriter, thereby promoting the sustainable development of the Group.
Analysis
Price Target
No Data
